Waters Corporation

WAT Healthcare Diagnostics & Research

Waters Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 6.99% from fiscal 2024. In the quarter to June 2026, revenue grew 113.4%, EPS fell 156.3%, free cash flow grew 750.0% and total debt rose 308.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.

436.95 7.20 −1.62%
Market cap
$43.6B
P/E
109×
Fwd P/E
44.3×
Dividend yield
—
F-score
5/9
Altman Z
9.63
Beneish M
−2.37
Dividend safety
n/a

Insider Decisions trades per month

Total buys 0.45
Total sells 1.44
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — 2 — — — — — — —
Sell — — — — — — — — — 1 — —
Insider Ownership 0.10%

Capital & Financial Ratios $m

Market Cap 43,640.00
Revenue 4,644.29
Net Income 166.63
Free Cash Flow 366.60
Net Debt 4,347.00
Current Ratio 1.86 (at or above 1.5: strong)
Debt/Equity 0.32 (at or below 0.5: strong)
P/E ratio 108.69 (above 35: high)
Fwd P/E 44.30 (above 35: high)
P/S ratio 9.24
P/B ratio 2.82
Past 5Y EPS Growth 5.18%
This Y EPS Growth 11.03%
Next Y EPS Growth 13.08%
Next Y revenue growth 104.34% (at or above 10%: strong)
Next 5Y EPS Growth 11.93%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/E against its own 10 years 90.60%
10-year low 10-year high
P/S against its own 10 years 98.89%
10-year low 10-year high
P/B against its own 10 years 5.45%
10-year low 10-year high
EV/Sales against its own 10 years 99.82%
10-year low 10-year high
EV/FCF against its own 10 years 97.77%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2025 Powerpack
2024 Powerpack
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2019 Powerpack
2017 Powerpack
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 396 325 588 539
Receivables 702 733 829 1,987
Inventory 516 477 572 1,377
Other 138 133 159 562
1,753 1,669 2,148 4,465
2023 2024 2025 Q'26
Payables 85 100 104 863
ST’ Debt — — — —
Other 169 149 231 545
790 790 1,239 2,399

Compound Annual Growth %

10y 5y 3y
Sales 4.48% 6.00% 2.12%
Cash Flow 1.30% (3.76%) 2.18%
Earnings 3.20% 4.26% (3.17%)
Book Value 2.21% 61.64% 71.87%

Revenue $m

Mar Jun Sep Dec Year
’26 1,267 1,645 — — —
’25 662 771 800 932 3,165
’24 637 709 740 873 2,958
’23 685 741 712 819 2,956
’22 691 714 709 859 2,972
’21 609 682 659 836 2,786
’20 465 520 594 787 2,365
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (3) 201 — — —
’25 260 41 187 165 653
’24 263 55 205 240 762
’23 197 18 158 230 603
’22 198 57 158 199 612
’21 218 143 168 218 747
’20 152 199 173 267 791
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (42) 153 — — —
’25 234 18 162 93 508
’24 234 18 179 188 620
’23 162 (28) 120 (1,094) (840)
’22 165 10 116 137 428
’21 179 99 128 173 579
’20 101 153 144 140 538
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 (0.87) (1.39) — — —
’25 2.03 2.47 2.50 3.77 10.76
’24 1.72 2.40 2.71 3.88 10.71
’23 2.38 2.55 2.27 3.65 10.84
’22 2.62 2.72 2.60 3.81 11.73
’21 2.37 2.69 2.60 3.52 11.17
’20 0.86 1.98 2.03 3.49 8.36
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.8
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 112.00 134.68 167.94 174.95 154.39 244.77 265.61 231.90 279.24 275.05

Analyst estimates 2026–2028

Powerpack
High 162.53 201.95 220.20 255.21 252.67 428.22 372.24 350.97 397.02 423.56
People
People Employees 6,900 7,000 7,200 7,500 7,400 7,800 8,200 7,900 7,600 7,900
Revenue/emp, $m 0.31 0.33 0.34 0.32 0.32 0.36 0.36 0.37 0.39 0.40
Income, $m
Income, $m Revenue 2,167 2,309 2,420 2,407 2,365 2,786 2,972 2,956 2,958 3,165
Gross margin, % 58.87 58.99 58.98 58.00 57.44 58.49 58.00 59.57 59.43 59.28
EBT 600 641 682 678 611 806 838 736 755 755
EBT margin, % 27.69 27.76 28.19 28.18 25.83 28.94 28.19 24.90 25.52 23.85
Net income 522 20 594 592 522 693 708 642 638 643
Depreciation 96 106 108 105 125 132 130 166 192 206
Per share, $
Per share, $ Revenue 26.83 28.94 31.43 35.59 38.09 45.24 49.55 50.04 49.86 53.19
Earnings 6.46 0.25 7.71 8.76 8.40 11.25 11.80 10.87 10.75 10.80
Cash flow 7.96 8.74 7.85 9.51 12.73 12.14 10.20 10.20 12.84 10.97
Capex (1.13) (1.13) (1.25) (2.42) (4.07) (2.73) (3.06) (24.43) (2.40) (2.44)
Free cash flow 6.83 7.61 6.60 7.09 8.66 9.40 7.14 (14.22) 10.44 8.53
Book value 28.49 27.99 20.36 (3.20) 3.74 5.97 8.41 19.47 30.82 43.04
Shares, m 81 80 77 68 62 62 60 59 59 60
Valuation, ×
Valuation, × P/E 21.09 815.38 24.37 26.40 29.49 33.06 29.24 30.18 34.48 35.20
P/S 5.09 6.76 6.00 6.57 6.50 8.24 6.98 6.57 7.44 7.14
P/B 4.79 6.99 9.27 0.00 66.18 62.42 41.09 16.88 12.04 8.82
EV/Sales 4.57 6.11 5.76 7.08 6.82 8.57 7.33 7.21 7.88 7.25
EV/FCF 18.50 23.25 27.69 35.94 30.28 41.26 50.85 (25.38) 37.62 45.24
Cash, $m
Cash, $m Operating cash flow 643 698 604 643 791 747 612 603 762 653
Capex (91) (90) (96) (164) (253) (168) (183) (1,443) (142) (145)
Free cash flow 552 607 508 479 538 579 428 (840) 620 508
Balance, $m
Balance, $m Working capital 3,115 3,664 2,214 721 596 948 978 963 879 908
Total debt 1,702 1,898 1,148 1,581 1,207 1,514 1,525 2,306 1,626 947
Net debt (1,111) (1,496) (587) 1,244 763 945 1,043 1,910 1,301 360
Shareholders’ equity 2,302 2,234 1,567 (216) 232 368 504 1,150 1,829 2,561
Returns, %
Returns, % ROA 11.68 0.41 13.12 18.85 19.33 23.35 22.20 16.24 13.90 13.35
ROIC 32.80 56.11 47.17 43.10 40.52 39.14 35.26 16.70 16.50 17.17
ROE 23.92 0.90 31.24 87.67 6,576.65 231.06 162.32 77.62 42.82 29.28
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Waters Corporation vs peers in Diagnostics & Research (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
NTRA Natera, Inc. $58.4B — (loss-making) — (loss-making) +37.71% (above 0%: growing) n/m −173.96% (below 0%: shrinking) 64.46% (10.07%) Compare
A Agilent Technologies, Inc. $49.5B 34.0× 26.3× +8.06% (above 0%: growing) +8.47% (above 0%: growing) +69.50% (above 0%: growing) 55.48% 23.64% Compare
IQV IQVIA Holdings Inc. $44.6B 32.8× 22.3× +8.74% (above 0%: growing) −0.65% (below 0%: shrinking) +23.29% (above 0%: growing) 32.85% 11.58% Compare
WAT Waters Corporation $43.6B 109× 44.3× +113.36% (above 0%: growing) n/m +750.00% (above 0%: growing) 44.62% (5.23%)
IDXX IDEXX Laboratories, Inc. $43.1B 39.1× 38.3× +9.66% (above 0%: growing) +17.21% (above 0%: growing) +111.44% (above 0%: growing) 64.04% 34.98% Compare
ILMN Illumina, Inc. $40.5B 48.4× 34.7× +9.44% (above 0%: growing) −8.05% (below 0%: shrinking) −18.27% (below 0%: shrinking) 66.44% 21.14% Compare
MTD Mettler-Toledo International, Inc. $32.8B 36.4× 25.5× +4.48% (above 0%: growing) +18.30% (above 0%: growing) +33.01% (above 0%: growing) 63.29% 30.61% Compare
DGX Quest Diagnostics Incorporated $26.4B 24.6× 20.8× +10.21% (above 0%: growing) +14.74% (above 0%: growing) +5.28% (above 0%: growing) 33.75% 15.08% Compare
LH Labcorp Holdings Inc. $26.4B 26.2× 19.0× +5.78% (above 0%: growing) +28.42% (above 0%: growing) −42.01% (below 0%: shrinking) 29.80% 12.10% Compare
Median of peers $41.8B 34.0× 25.5× +9.09% +14.74% +14.29% 59.39% 18.11%

All 52 Diagnostics & Research stocks →

WAT metrics, ten years each

Waters Corporation (WAT) key facts

  • Strength: Waters Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 6.99% from fiscal 2024.
  • Waters Corporation (WAT) is a Diagnostics & Research company in the Healthcare sector, listed on the New York Stock Exchange.
  • As of October 16, 2026, WAT traded at $436.95, a market capitalization of $43.6 billion.
  • Return on equity was 29.3% and debt-to-equity 0.32.
  • Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 9.63 (safe zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Waters Corporation (WAT) Latest News

23 Sep

11 Aug

Impact 3 · transcript

9 Aug

Impact 3 ·
stockrow.com/WAT · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com